• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRE

FIREBRICK PHARMA LIMITED - Charts / Financials

3.90% ! 8.0¢
Market Cap $18.18M  !
Healthcare Biotechnology
Add to My Watchlist

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available
View the full Corporate Spotlight arrow Created with Sketch.

FIREBRICK PHARMA - JUNE INVESTOR WEBINAR
refresh Created with Sketch. REFRESH
Last update - 16.20pm 28/07/2025 (20 minute delay) ?
Day
Open 8.0¢   Day High 8.0¢   Day Low 8.0¢
Daily Volume 50000
Bids   Sellers
Number Price Volume   Number Price Volume
1 8.1¢ 72   1 8.5¢ 26000

Directors & Senior Management

Dr. Peter Molloy Chief Executive Officer, Founder, Executive Chairman of the Board
Mr. Stephen Francis Goodall Founder, Chief Operating Officer, Executive Director
Mr. Kavi Bekarma Chief Financial Officer
Mr. Stephen Buckley Company Secretary
Dr. Phyllis Gardner Non-Executive Director
Mr. Peter Kash Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.0¢ 		Change
0.003(3.90%) 		Mkt cap ! $18.18M
Open High Low Value Volume
8.0¢ 8.0¢ 8.0¢ $4K 50K

Buyers (Bids)

No. Vol. Price($)
1 72 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 26000 1
View Market Depth
Last trade - 14.47pm 28/07/2025 (20 minute delay) ?

Top Stories

Clarity confidence – and share price – up on bumper $203M institutional placement

Clarity Pharmaceuticals (ASX:CU6) is heading towards Monday close up nearly +4% after the clinical-stage radiopharmaceutical company heralded the completion of a blockbuster $203 million institutional placement.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigge...
Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28 Boss Energy (ASX:BOE) is the first top-trender on HotCopper forums in Week 31, with the uranium producer wowing holders and traders alike with its FY26 guidance for its Honeymoon Operation in South Australia.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest ...
ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28 The Australian sharemarket has shaken off a two-day red trend to close out Week 31’s first day up at around 8,700 points. Positive tariffs sentiments and a strengthening coin Down Under both helped the ASX to the green close.Listen to the HotCopper podcast for in-depth discussions...
Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon Boss Energy (ASX:BOE) has dived hard through Monday trade today, with the much-followed energy stock losing as much as -42% in value after warning shareholders there may be @potential challenges” hitting nameplate capacity coming at its Honeymoon uranium project in South Aus...
Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 30 epis...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.